Trump Media Launches Paid Wall Street Feed for 'Market-Moving' Posts
Trump Media & Technology Group is launching a paid service to provide Wall Street firms with instant access to influential Truth Social posts, aiming to capital...
#WallStreet
The #WallStreet tag covers high-stakes financial moves, from Trump Media's paid market insights to Eli Lilly's $6.3B sleep drug acquisition and Nasdaq's IPO speed boost. These stories reveal how money, power, and innovation collide—perfect for creators to dissect trends, predict impacts, or add a finance twist to their content while the news is hot.
More coverage of WallStreet
Eli Lilly’s $6.3B Centessa Deal Signals Sleep Drug Race
Eli Lilly is reportedly acquiring sleep-drug maker Centessa for $6.3B, underscoring how aggressively big pharma is moving to secure differentiated CNS and sleep...
Nasdaq Cuts Big IPO “Fast Entry” to 15 Days
Nasdaq is accelerating its “fast entry” timeline for large-cap IPOs to as little as 15 days, signaling a push to modernize public listings and capture issuer de...
Goldman Signals Deal Boom as Wall Street Eyes Upside
Goldman Sachs is signaling that rising deal activity (M&A, capital markets, advisory) could help it beat targets as Wall Street’s risk appetite returns. This ma...
Goldman Predicts Target Beats as Deal-Making Surges
Goldman Sachs is signaling confidence that Target may beat expectations, tying the call to an improving backdrop for deals and corporate activity. It matters no...
Content hooks for #WallStreet
- What if your social media posts were worth millions to Wall Street?
- Trump Media just turned tweets into a premium financial product - here's how
- Milliseconds matter in trading. Now you can buy early access to market-moving Truth Social posts
- $6.3B for sleep drugs—what does Eli Lilly see that the market missed?
- If you think sleep is a ‘wellness’ topic, this acquisition says otherwise.
- This is what pharma does when the pipeline clock starts ticking.
- If you think IPOs take months, Nasdaq just changed the timeline.
- A 15-day IPO sounds efficient—until you realize what it breaks.
- This is how exchanges are quietly rewriting the rules of going public.
Ready-to-post tweets
BREAKING: Trump Media to sell Wall Street instant access to Truth Social posts - turning market-moving tweets into a premium product. Would you pay for early access? #TruthSocial #WallStreet
Milliseconds matter in trading. Now institutions can buy them from Truth Social. Retail investors? You'll have to wait. #MarketData #FinTech
Eli Lilly reportedly buying Centessa for $6.3B is a loud signal: sleep medicine is no longer “niche”—it’s strategic. CNS is back (if you can prove safety + real-world outcomes).
$6.3B for a sleep-drug maker. Translation: big pharma would rather buy de-risked shots on goal than wait 7–10 years for internal R&D to deliver.